Toward Biomarker-Guided Treatment in Psychosis

Is oxidative stress a therapeutic target in schizophrenia?

Related Videos
Related Content

From the Pages of Psychiatric Times: May 2023

May 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Poster Highlights Racial/Ethnic Disparities in LAI Use

May 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Exploring the Future of Mental Health

May 19th 2023

The Week in Review: May 8-12

May 13th 2023

From the Pages of Psychiatric Times: May 2023

May 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Poster Highlights Racial/Ethnic Disparities in LAI Use

May 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Exploring the Future of Mental Health

May 19th 2023

The Week in Review: May 8-12

May 13th 2023

From the Pages of Psychiatric Times: May 2023

May 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Poster Highlights Racial/Ethnic Disparities in LAI Use

May 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Exploring the Future of Mental Health

May 19th 2023

The Week in Review: May 8-12

May 13th 2023
© 2023 MJH Life Sciences

All rights reserved.